Der bør udvises forsigtighed ved samtidig administration af Tasigna og substrater af disse enzymer, der har et smalt terapeutisk indeks (f. eks. astemizol, terfenadin, cisaprid, pimozid, quinidin, bepridil eller ergotalkaloider (ergotamin, dihydroergotamin)).
Caution should be exercised when co-administering Tasigna with substrates of these enzymes that have a narrow therapeutic index [e. g. astemizole, terfenadine, cisapride, pimozide,